Azienda Ospedaliero-Universitaria Maggiore Della Carita — Sponsor Intelligence | 5 EU Trials

Filter these 5 trials by condition, phase, country and more.

5 Registered trials

0 Recruiting

0 Completed trials

1 Countries active

6 Unique IMPs

N/A Results reported

Phase II

Phase III/IV

Phase IV

Top indications

5 total

MEDICAL CANNABIS TREATMENT IN NEURODEGENERATIVE DISEASES (NEUROBIS) Pending

2023-507715-35-02 Phase II 1 country DRONABINOL, CANNABIDIOL
ARMYDA TICA-MI study Pending

2024-511944-18-01 Phase IV 1 country CANGRELOR TETRASODIUM; TICAGRELOR
Vitamin D as add-on treatment option of pneumonia and sepsis in elderly subjects (TreatViD) Pending

2024-515978-27-00 Phase III/IV 1 country COLECALCIFEROL
Early use of dapagliflozin in patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 Dapagliflozin… Pending

2025-521481-10-00 Phase IV 1 country DAPAGLIFLOZIN
ARMYDA - 10 study Pending

2025-523977-40-00 Phase IV 1 country SEMAGLUTIDE

Showing 1–5 of 5 trials